StockData
NEUROONE MEDICAL TECHNOLOGIES Corp logo

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock

NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)

Close on Nov 17, 2026Market cap $6.43MP/E –Yield –

Neuroone Medical Technologies enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Neuroone Medical Technologies's enterprise value was $4.94M on Nov 11, 2026, against $28.17M a year earlier. Over the last 5 years it ranged from -$3.55M to $37.68M, with a median of $18.65M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.94M-84.2%
2025Dec 31, 2025$31.33M+30.6%
2024Dec 31, 2024$23.99M-26.6%
2023Dec 29, 2023$32.67M+287.2%
2022Dec 30, 2022$8.44M-49.2%
2021Dec 31, 2021$16.60M-48.2%
2020Dec 31, 2020$32.05M+69.2%
2019Dec 31, 2019$18.95M-56.9%
2018Dec 31, 2018$43.96M+39.1%
2017Dec 29, 2017$31.59M–

More Neuroone Medical Technologies figures

See a number that looks wrong?